pillbase.ru

Zyclara

Active substance: imiquimod

CREAM · IMIQUIMOD 37.5 mg/g

United StatesActive

Marketing holder: Bausch Health US, LLC

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 3
  • Aldara
    imiquimod
    EMEA/H/C/000179
    Viatris Healthcare Limited
  • Zyclara
    imiquimod
    EMEA/H/C/002387
    Viatris Healthcare Limited
  • Zartra
    imiquimod
    EMEA/H/C/000180
    Laboratoires 3M Santé
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-71de-77dd-8a50-27e3b5dd2f98,01a1208c-fdd3-77f7-843b-c85d41ebb8b2,01a1208d-f492-7b16-96f9-d99fde0dd9ba,01a1208e-f23c-7f93-9e5b-4fdcf1551d1e,01a12091-6764-7d0a-8c0a-d4deb4f3a5ad;count=14 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
99207-270
Registration status
Active
Dispensing
Prescription only
Route
TOPICAL
Sources
  • product · openFDA NDC · 99207-270 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 99207-270 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 99207-270 · Verified 2026-10-09 · open in source